NASDAQ$CAI
Caris Life Sciences Inc · Q2 2026 earnings
Q2 2026 earnings · · After market close
Reports in 4 weeks
Caris Life Sciences Inc hasn't published Q2 2026 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q1 2026
- Revenue
- $216M
- EPS
- $0.00
Year-ago · Q2 2025 Q2 2025
- Revenue
- $181M
- EPS
- -$7.97
Revenue & EPS history
Caris Life Sciences Inc · Revenue · Quarterly
$216M
Q1 2026
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports
-5.8%
Avg return
Earnings day
-8.5%
Avg return
5 days after
-3.7%
Avg return
30 days after
33%
1 / 3 earnings
Positive
+7.4%
Q2 2025
Best reaction
-18.6%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -18.6% | -26.0% | -16.8% | |
| Q3 2025 | -6.3% | -20.5% | -7.4% | |
| Q2 2025 | +7.4% | +20.8% | +13.2% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro